You are here: Industry Insights > Development

News List

KIO, Pfizer Enter Research Collaboration contractpharma
December 18, 2018
Kineta Immuno-Oncology has entered into a strategic research collaboration with Pfizer Inc. to develop RIG-I agonist immunotherapies for the treatment of cancer.
Celgene Licenses Two Dragonfly Immunotherapy Candidates contractpharma
December 17, 2018
Dragonfly Therapeutics, Inc. has licensed two TriNKET immunotherapy drug candidates to Celgene Corp. and its affiliates for $12 million each plus milestones and royalties.
AC Immune & Lilly Partner for Alzheimer's contractpharma
December 17, 2018
AC Immune SA and Eli Lilly and Company have signed a license and collaboration agreement to research and develop tau aggregation inhibitor small molecules for the potential treatment
PPD Adds New Therapeutic Area Leaders contractpharma
December 14, 2018
PPD has appointed Darell Heiselman, D.O., to lead cardiovascular and critical care and David Klein, M.D., Ph.D., to oversee endocrinology, metabolism and diabetes.
WuXi AppTec Expands San Diego Site contractpharma
December 13, 2018
WuXi AppTec's newly expanded facility will establish a center of excellence in screening, discovery biology, pharmacology, and small molecule process R&D including phase I GMP manufacturing.
InveniAI, Kyowa Hakko Kirin Partner for Drug Discovery contractpharma
December 12, 2018
InveniAI Corporation, a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML), has entered a collaboration agreement with Kyowa Hakko Kirin to use AI and ML for drug discovery.
Rho Adds Regulatory Strategy and Submissions Biz contractpharma
December 12, 2018
Rho, a full-service CRO, has added a new Regulatory Strategy and Submissions business segment to support the planning, development and submission of marketing applications, including.
Onconova Appoints Corporate Development VP contractpharma
December 12, 2018
Onconova Therapeutics announced that Mr. Abraham “Avi” Oler has joined Onconova’s management team as vice president, Corporate Development and General Counsel.
UK Government announces first-of-its-kind Vaccines Manufacturing Innovation Centre pharmafile
December 07, 2018
Plans for a Vaccines Manufacturing Innovation Centre in the UK have been unveiled by Business Secretary Greg Clark, in a bid to help tackle deadly diseases around the world and boost growth of the country’s £70 billion life sciences industry.
Fette Compacting COO to Depart contractpharma
December 03, 2018
Stefan Moll belonged to the Management Board of Fette Compacting since October 2016. From this date, Stefan Moll assumed responsibility for Production, R&D/Engineering and Processes/Quality.

Previous page 1 2 3 4 5 6 7 Next page